Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b

Authors

Institutions

Publication Details

Journal
Cardio-Oncology
Published
2025-05-02
DOI
https://doi.org/10.1186/s40959-025-00339-0
Citations
4
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
5.55

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b

Edward T.H. Yeh, Hui‐Ming Chang, Chul Soo Ahn, J.C. Hsu
4 citations
Cardio-Oncology
Chemotherapy-induced cardiotoxicity and mitigation
5.55
article

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b

Edward T.H. Yeh, Hui‐Ming Chang, Chul Soo Ahn, J.C. Hsu
article en
4 citations

Abstract

No abstract available for this paper.
Cardio-OncologyVol. 11(1)
University of Arkansas for Medical Sciences (US), The University of Texas Southwestern Medical Center (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 4%
Chemotherapy-induced cardiotoxicity and mitigation
5.55
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.